Deborah Atherly

1.9k total citations
24 papers, 932 citations indexed

About

Deborah Atherly is a scholar working on Infectious Diseases, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Deborah Atherly has authored 24 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Hepatology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Deborah Atherly's work include Viral gastroenteritis research and epidemiology (15 papers), Hepatitis Viruses Studies and Epidemiology (15 papers) and Viral Infections and Immunology Research (7 papers). Deborah Atherly is often cited by papers focused on Viral gastroenteritis research and epidemiology (15 papers), Hepatitis Viruses Studies and Epidemiology (15 papers) and Viral Infections and Immunology Research (7 papers). Deborah Atherly collaborates with scholars based in United States, United Kingdom and Gambia. Deborah Atherly's co-authors include Gisela Kobelt, Olympia Hadjimichael, Jenny Berg, Umesh D. Parashar, Richard Rheingans, Jacqueline E. Tate, Clint Pecenka, John Anderson, Kristen Lewis and Carol Levin and has published in prestigious journals such as PLoS ONE, Neurology and Clinical Infectious Diseases.

In The Last Decade

Deborah Atherly

24 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Atherly United States 18 478 272 209 186 172 24 932
Linda Aurpibul Thailand 19 807 1.7× 85 0.3× 36 0.2× 51 0.3× 14 0.1× 89 1.3k
Stuart Carroll United Kingdom 14 134 0.3× 88 0.3× 40 0.2× 144 0.8× 31 0.2× 57 667
Negar Aliabadi United States 15 518 1.1× 124 0.5× 56 0.3× 27 0.1× 260 1.5× 43 847
Sabeena Setia United States 5 611 1.3× 166 0.6× 6 0.0× 168 0.9× 339 2.0× 6 1.0k
Virginie Masserey Spicher Switzerland 14 289 0.6× 140 0.5× 7 0.0× 134 0.7× 42 0.2× 25 691
Jamal Ahmed United States 16 441 0.9× 16 0.1× 47 0.2× 77 0.4× 255 1.5× 42 842
Sharmeel K. Wasan United States 15 230 0.5× 44 0.2× 9 0.0× 118 0.6× 137 0.8× 49 1.2k
É. Rouveix France 15 464 1.0× 122 0.4× 81 0.4× 28 0.2× 38 0.2× 77 948
Asia Khan Pakistan 12 134 0.3× 140 0.5× 9 0.0× 38 0.2× 72 0.4× 15 559
Ikechukwu U. Ogbuanu United States 19 229 0.5× 38 0.1× 10 0.0× 405 2.2× 38 0.2× 32 794

Countries citing papers authored by Deborah Atherly

Since Specialization
Citations

This map shows the geographic impact of Deborah Atherly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Atherly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Atherly more than expected).

Fields of papers citing papers by Deborah Atherly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Atherly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Atherly. The network helps show where Deborah Atherly may publish in the future.

Co-authorship network of co-authors of Deborah Atherly

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Atherly. A scholar is included among the top collaborators of Deborah Atherly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Atherly. Deborah Atherly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Debellut, Frédéric, Andrew Clark, Clint Pecenka, et al.. (2021). Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study. The Lancet Global Health. 9(7). e942–e956. 16 indexed citations
2.
Yeung, Karene Hoi Ting, Shi Lin Lin, Andrew Clark, et al.. (2020). Economic evaluation of the introduction of rotavirus vaccine in Hong Kong. Vaccine. 39(1). 45–58. 2 indexed citations
3.
Debellut, Frédéric, Andrew Clark, Clint Pecenka, et al.. (2019). Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study. The Lancet Global Health. 7(12). e1664–e1674. 49 indexed citations
4.
Hendrix, Nathaniel, Naor Bar‐Zeev, Deborah Atherly, et al.. (2017). The economic impact of childhood acute gastroenteritis on Malawian families and the healthcare system. BMJ Open. 7(9). e017347–e017347. 19 indexed citations
5.
Nonvignon, Justice, Deborah Atherly, Clint Pecenka, et al.. (2017). Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031. Vaccine. 36(47). 7215–7221. 24 indexed citations
6.
Pecenka, Clint, Umesh D. Parashar, Jacqueline E. Tate, et al.. (2017). Impact and cost-effectiveness of rotavirus vaccination in Bangladesh. Vaccine. 35(32). 3982–3987. 33 indexed citations
7.
Ngabo, Fidèle, Mercy Mvundura, Maurice Gatera, et al.. (2016). The Economic Burden Attributable to a Child’s Inpatient Admission for Diarrheal Disease in Rwanda. PLoS ONE. 11(2). e0149805–e0149805. 38 indexed citations
8.
Bar‐Zeev, Naor, Jacqueline E. Tate, Clint Pecenka, et al.. (2016). Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient–Level Costing Data. Clinical Infectious Diseases. 62(suppl 2). S220–S228. 29 indexed citations
9.
Usuf, Effua, Grant Mackenzie, Sana Sambou, Deborah Atherly, & Chutima Suraratdecha. (2016). The economic burden of childhood pneumococcal diseases in The Gambia. Cost Effectiveness and Resource Allocation. 14(1). 4–4. 20 indexed citations
10.
Shen, Angela K., Jonathan M. Weiss, Jon Kim Andrus, et al.. (2016). Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction. Health Affairs. 35(2). 272–276. 13 indexed citations
11.
Atherly, Deborah, et al.. (2015). Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis. Vaccine. 33. A119–A125. 15 indexed citations
12.
Jaúregui, Bárbara, Cara Bess Janusz, Julia J. C. Blau, et al.. (2015). Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience. Vaccine. 33. A28–A33. 22 indexed citations
13.
Usuf, Effua, et al.. (2014). Costs of vaccine delivery in the Gambia before and after, pentavalent and pneumococcal conjugate vaccine introductions. Vaccine. 32(17). 1975–1981. 20 indexed citations
14.
Rheingans, Richard, et al.. (2014). Estimated impact and cost-effectiveness of rotavirus vaccination in India: Effects of geographic and economic disparities. Vaccine. 32. A140–A150. 27 indexed citations
15.
Atherly, Deborah, et al.. (2013). Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries. Human Vaccines & Immunotherapeutics. 9(9). 1894–1902. 24 indexed citations
16.
Atherly, Deborah, Kristen Lewis, Jacqueline E. Tate, Umesh D. Parashar, & Richard Rheingans. (2012). Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030. Vaccine. 30. A7–A14. 77 indexed citations
17.
Rheingans, Richard, Deborah Atherly, & John Anderson. (2012). Distributional impact of rotavirus vaccination in 25 GAVI countries: Estimating disparities in benefits and cost-effectiveness. Vaccine. 30. A15–A23. 53 indexed citations
18.
Sanders, John W., et al.. (2012). Effectiveness of rifaximin and fluoroquinolones in preventing travelers’ diarrhea (TD): a systematic review and meta-analysis. Systematic Reviews. 1(1). 39–39. 30 indexed citations
19.
Atherly, Deborah, Robert Dreibelbis, Umesh D. Parashar, et al.. (2009). Rotavirus Vaccination: Cost‐Effectiveness and Impact on Child Mortality in Developing Countries. The Journal of Infectious Diseases. 200(s1). S28–S38. 73 indexed citations
20.
Levin, Carol, Deborah Atherly, Sandra G. García, et al.. (2007). Analysis of the Operational Costs of Using Rapid Syphilis Tests for the Detection of Maternal Syphilis in Bolivia and Mozambique. Sexually Transmitted Diseases. 34(7). S47–S54. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Aurpibul Breakdown of academic impact, for papers by Stuart Carroll Breakdown of academic impact, for papers by Negar Aliabadi Breakdown of academic impact, for papers by Sabeena Setia Breakdown of academic impact, for papers by Virginie Masserey Spicher Breakdown of academic impact, for papers by Jamal Ahmed Breakdown of academic impact, for papers by Sharmeel K. Wasan Breakdown of academic impact, for papers by É. Rouveix Breakdown of academic impact, for papers by Asia Khan Breakdown of academic impact, for papers by Ikechukwu U. Ogbuanu
Rankless by CCL
2026